Results 161 to 170 of about 58,634 (303)

Prolonged ventricular fibrillation in a patient with left ventricular assist device

Türk Kardiyoloji Derneği Arşivi, 2018
Serkan Çay, Fırat Özcan, Özcan Özeke, Dursun Aras, Serkan Topaloğlu   +4 more
doaj   +1 more source

Ultraslow deflation automated sphygmomanometry in continuous-flow-left ventricular assist device patients. [PDF]

Am Heart J Plus
Hendricks E, Calkins T, Cohen T, Parker AM, Vilaro JR, Aranda JM, Ahmed MM.   +6 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Ivor Lewis esophagectomy in a patient with left ventricular assist device. [PDF]

JTCVS Tech
Barbarino A, Peel JK, Fong KL, White ANJ, Kim JJ, Chen EX, Billia F, Rao V, Yeung JC.   +8 more
europepmc   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Temporary Left Ventricular Assist Device for Peripartum Cardiogenic Shock as a Bridge to Cesarean Delivery. [PDF]

JACC Case Rep
Van Oosbree A, Samson M, Gore A, Nielsen C, Atkins JL, Heinke T, Chang E, Goodier C, McElwee E, Rao VN.   +9 more
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Updates to perioperative and anesthetic management of the left ventricular assist device patient presenting for noncardiac surgery. [PDF]

Curr Opin Anaesthesiol
Burcar KH, Korenke MM, Ebadi-Tehrani MM, Mathis MR, Toton MP.   +4 more
europepmc   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Left ventricular assist device utilization across the different regions of the Netherlands. [PDF]

Neth Heart J
Drost VCE, Wösten M, Otterspoor LC, Damman K, Tops LF, Gianoli M, Kuijpers M, Palmen M, Sjatskig J, Yazdanbakhsh AP, Caliskan K, Van Laake LW.   +11 more
europepmc   +1 more source